Post-Covid Conundrum

Event Details

When: August 19, 2021 @ 2:00PM EDT On-Demand Where: Online Event Online Event

Presented by: Tammy Bradly, VP Clinical Product Development

More than 30 million Americans have contracted and survived the COVID-19 virus. While many thought they had weathered the worst of the pandemic when their symptoms abated, researchers claim as many as one-third of this group continue to experience long-term symptoms since onset, despite the severity of their initial diagnosis. The uncertainty of long-haul COVID is leaving many workers’ comp professionals puzzled about the virus’s current and long-term effects on the industry.

This webinar has passed. If you missed the live presentation, you can access the webinar recording and slides below.

Slides | Recording

Watch On-Demand

Please note that you can not receive CE credits for watching past webinars.

More stories

Mitchell News Release

Washington State Updates Workers' Compensation Drug Formulary

March 24, 2020

Recent updates adopted by the Washington State Department of Labor and Industries to its workers' compensation drug formulary.

Mitchell News Release

New York Updates Workers' Comp Drug Formulary

March 24, 2020

Updates to drug formulary adopted under emergency rulemaking by the New York State Workers' Compensation Board.

Workers' Comp Blog

Why Use Antidepressants to Treat Pain?

March 23, 2020

Why use antidepressants to treat pain? The nation’s focus on the ongoing opioid epidemic and stricter guidelines on opioid prescribing has led to an increased utilization of non-opioid pain treatments in workers’ compensation. In a previous blog post, we looked at the use of anticonvulsants to treat pain because of their ability to create effective pain relief without the cravings, tolerance, or addiction issues that are typically associated with narcotics. Another therapeutic class commonly used to treat chronic pain is antidepressants, which may even be prescribed when depression is not a diagnosed condition for the injured worker.

Mitchell News Release

COVID-19 Update

March 20, 2020

Mitchell is prioritizing the health and safety of our employees while maintaining commitments to all of our customers and partners.

Workers' Comp Article

Topical Medications in Workers' Compensation and Auto Casualty

March 18, 2020

This article is part of our ongoing Quarterly Drug Update series. View our last article on gabapentinoids. Topical medications are an important part of care in the workers’ compensation and auto casualty industries, providing relief for patients in pain. In the past few years, the variety of available topical medications has increased, which has also driven up the number of prescriptions, particularly for new analgesic and local anesthetic drugs. While this variety allows for greater choice, many of the new branded medications are very expensive.

Mitchell News Release

Mitchell Pharmacy Solutions Responds to COVID-19 National Emergency

March 17, 2020

Pharmacy protocols in place to respond to emergency declarations.